Supplemental Material, PDL1_supportingInfo_ejagoda_(1) - Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab

Jagoda, Elaine M.; Vasalatiy, Olga; Basuli, Falguni; Christina L. Opina, Ana; Williams, Mark R.; Wong, Karen; Lane, Kelly C.; Adler, Steve; Ton, Anita Thein; Szajek, Lawrence P.; Xu, Biying; Butcher, Donna; Edmondson, Elijah F.; Swenson, Rolf E.; Greiner, John; Gulley, James; Eary, Janet; Choyke, Peter L.

doi:10.25384/SAGE.8075621.v1

PDL1_supportingInfo_ejagoda_(1).pdf (570.2 kB)

Supplemental Material, PDL1_supportingInfo_ejagoda_(1) - Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab

journal contribution

posted on 2019-05-02, 12:00 authored by Elaine M. Jagoda, Olga Vasalatiy, Falguni Basuli, Ana Christina L. Opina, Mark R. Williams, Karen Wong, Kelly C. Lane, Steve Adler, Anita Thein Ton, Lawrence P. Szajek, Biying Xu, Donna Butcher, Elijah F. Edmondson, Rolf E. Swenson, John Greiner, James Gulley, Janet Eary, Peter L. Choyke

Supplemental Material, PDL1_supportingInfo_ejagoda_(1) for Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab by Elaine M. Jagoda, Olga Vasalatiy, Falguni Basuli, Ana Christina L. Opina, Mark R. Williams, Karen Wong, Kelly C. Lane, Steve Adler, Anita Thein Ton, Lawrence P. Szajek, Biying Xu, Donna Butcher, Elijah F. Edmondson, Rolf E. Swenson, John Greiner, James Gulley, Janet Eary and Peter L. Choyke in Molecular Imaging